Kombucha as a Functional Fermented Beverage: Emerging Clinical Evidence, Proposed Mechanisms, Sensory Dimensions, Cultural Context, and Implications for Global Health

Kombucha is a fermented tea beverage produced by a symbiotic culture of bacteria and yeast (SCOBY) containing a complex matrix of organic acids, polyphenols, electrolytes, and live microorganisms. Tea is the world’s most widely consumed beverage after water, and fermentation transforms its sensory properties in ways that have contributed to kombucha’s growing global popularity alongside its perceived health benefits; yet, despite widespread consumption and long-standing traditional use, controlled human data are relatively recent and sparse. This review integrates clinical, mechanistic, sensory, cultural, and public health perspectives to evaluate kombucha as a functional fermented beverage. A randomised, placebo-controlled crossover trial demonstrated that consumption of live kombucha with a high-glycaemic-index meal significantly reduced postprandial glycaemia and insulinaemia, lowering the glycaemic index from 86 to 68 (approximately 20% reduction). A pilot randomised controlled study in adults with type 2 diabetes reported reductions in fasting blood glucose following four weeks of regular kombucha consumption. Most recently, a 10-week RCT in adults with excess body weight demonstrated significant within-group reductions in total cholesterol, LDL-c, VLDL-c, triglycerides, Castelli II index, and uric acid, as well as reduced hydrogen peroxide levels and improved gastrointestinal symptoms, following daily green tea kombucha consumption combined with an energy-restricted diet. Mechanistically, these effects likely arise from synergistic interactions between organic acids, polyphenols, vitamins, minerals, and microbial communities influencing gastric emptying, carbohydrate and lipid digestion, gut microbiota composition, antioxidant defence, and hydration physiology. While promising, current evidence requires confirmation in larger, longer-term trials before definitive clinical recommendations can be made.